Erythropoietin in Management of Neonatal Hypoxic Ischemic Encephalopathy

NCT03163589 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Hypoxic-Ischemic Encephalopathy

Interventions

DRUG: Erythropoietin
DRUG: normal saline

Sponsor

Assiut University